Description
In this episode, the discussants examines the following questions, raised after a Journal of Hepatology’s nomenclature article:
- Is the introduction of metabolic risk factors (MRF) for the definition of MASLD justified?
- What are the main issues regarding the measurement and thresholds for MRFs?
- Is the introduction of the MetALD category clinically justified?
- Is it necessary to worry about MRFs in a patient drinking increased or excessive amounts of alcohol and if yes, how should these be accounted for in disease classification systems?
Faculty
- Vlad Ratziu (Moderator)
- Giulio Marchesini (Faculty)
- Nancy Reau (Faculty)
- Roberto Vettor (Faculty)
Related article
Related episodes
- EASL Studio from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclature
ℹ️ Please click here to access the podcast version of this EASL Studio episode.